E Fenig Selected Research

Palliative Care (Palliative Therapy)

5/2001	Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction.
3/2000	[High dose endobronchial brachytherapy for malignant airway obstruction: first study of 30 patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Fenig Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 02/2000
6	Breast Neoplasms (Breast Cancer) 06/2007 - 05/2000
2	Ewing Sarcoma (Sarcoma, Ewing) 06/2007 - 05/2005
2	Melanoma (Melanoma, Malignant) 05/2005 - 02/2000
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2001 - 02/2001
2	Airway Obstruction (Choking) 05/2001 - 03/2000
2	Hodgkin Disease (Hodgkin's Disease) 02/2001 - 05/2000
2	Neoplasm Metastasis (Metastasis) 04/2000 - 02/2000
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2006
1	Inflammatory Breast Neoplasms 12/2002
1	Necrosis 05/2001
1	Second Primary Neoplasms (Neoplasms, Second) 04/2001
1	Dermatitis 03/2001
1	Congenital Abnormalities (Deformity) 02/2001
1	Merkel Cell Carcinoma 02/2000
1	Sarcoma (Soft Tissue Sarcoma) 01/2000

Drug/Important Bio-Agent (IBA)

2	Imatinib Mesylate (Gleevec)FDA Link 06/2007 - 05/2005
1	B7-H1 AntigenIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	IpilimumabIBA 01/2022
1	NivolumabIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 06/2007
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2001
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2001
1	Ointments (Pastes)IBA 03/2001
1	LipidermIBA 03/2001
1	BiafineIBA 03/2001
1	Biological ProductsIBA 02/2000
1	Etoposide (VP 16)FDA LinkGeneric 02/2000
1	Topoisomerase II InhibitorsIBA 02/2000
1	Pharmaceutical PreparationsIBA 02/2000
1	Gemcitabine FDA Link 01/2000
1	Ifosfamide FDA LinkGeneric 01/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2000

Therapy/Procedure

4	Radiotherapy 01/2006 - 05/2000
2	Segmental Mastectomy (Lumpectomy) 01/2006 - 12/2002
2	Drug Therapy (Chemotherapy) 12/2002 - 01/2000
2	Brachytherapy 05/2001 - 03/2000
2	Palliative Care (Palliative Therapy) 05/2001 - 03/2000
2	Lymph Node Excision (Lymph Node Dissection) 04/2000 - 02/2000
1	Conservative Treatment 01/2006
1	Induction Chemotherapy 12/2002
1	Aftercare (After-Treatment) 04/2001
1	Contraindications 02/2001
1	Prophylactic Mastectomy 05/2000
1	Catheters 03/2000
1	Bronchoscopes 03/2000